Leverone Jason A.
SEC CIK 1692747 · EDGAR
BoughtSold
Companies
| Ticker | Company | Title | Holding | Bought | Sold | Trades | First | Last |
|---|---|---|---|---|---|---|---|---|
| OKUR | OnKure Therapeutics, Inc. | CFO | 18.5K | — | $15.1K | 8 | 2024-10-04 | 2026-09-21 |
Most active insiders at OKUR, 12 months
| # | Insider | Title | Bought | Sold |
|---|---|---|---|---|
| 1 | Leverone Jason A. | CFO | — | $4,379 |
| 2 | Saccomano Nicholas A | Pres, CEO, Dir | — | $1,253 |
| 3 | Manke Isaac | Dir | — | — |
| 4 | Mathers Edward T | Dir | — | — |
Transactions 8
| X | Filed | Traded | Ticker | Company | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-09-23 16:52 | 2026-09-21 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $2.97 | -302 | 18.5K | -2% | -$898.21 | |
| 2026-06-24 19:27 | 2026-06-22 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $4.40 | -303 | 18.8K | -2% | -$1,332 | |
| 2026-03-24 | 2026-03-23 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $4.16 | -301 | 16.0K | -2% | -$1,252 | |
| 2025-12-23 | 2025-12-22 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $2.97 | -302 | 16.3K | -2% | -$896.94 | |
| 2025-09-24 | 2025-09-22 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $2.62 | -303 | 12.6K | -2% | -$793.86 | |
| 2025-06-25 | 2025-06-23 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $2.38 | -303 | 12.9K | -2% | -$721.14 | |
| M | 2025-04-08 | 2025-04-04+ | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | S - Sale | $2.94 | -3,122 | 13.2K | -19% | -$9,179 |
| D | 2024-10-08 | 2024-10-04 | OKUR | OnKure Therapeutics, Inc. | Leverone Jason A. | CFO | A - Grant | — | +16.3K | 16.3K | New | — |
Purchase Sale Sale after option exercise All abbreviations